Procalcitonin vs clinical and chest film findings to diagnose community-acquired pneumonia in patients with acute asthma or acute exacerbations of chronic bronchitis

Chest

Volumn 140, Issue 6, 2011, Pages 1667-1668

  Cunha, Burke A ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN;

ANAMNESIS; ASTHMA; CHLAMYDOPHILA PNEUMONIAE; CHRONIC BRONCHITIS; CLINICAL EXAMINATION; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DISEASE PREDISPOSITION; FEVER; HAEMOPHILUS INFLUENZAE; HEALTH STATUS; HUMAN; HYPERINFLATION; INTERMETHOD COMPARISON; LETTER; LUNG INFILTRATE; MEDICAL DECISION MAKING; MORAXELLA CATARRHALIS; MYCOPLASMA PNEUMONIAE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESPIRATORY VIRUS; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY;

EID: 83455163088     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1705     Document Type: Letter

References (5)

1. Bafadhel M, Clark TW, Reid C, et al. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD. Chest. 2011;139(6):1410-1418.
2. Cunha BA. Empiric antimicrobial therapy of communityacquired pneumonia: clinical diagnosis versus procalcitonin levels . Scand J Infect Dis. 2009;41(10):782-784.
3. Cunha BA, ed. Pneumonia Essentials. 3rd ed. Sudbury, MA: Jones & Bartlett; 2010.
4. Marrie TJ, ed. Community-Acquired Pneumonia. New York, NY: Kluwer Academic/Plenum Publishers; 2001 .
5. Christ-Crain M, Opal SM. Clinical review: the role of biomarkers in the diagnosis and management of communityacquired pneumonia. Crit Care. 2010;14(1):203.